Infliximab for the Treatment of Moderate-to-Severe Psoriasis: Response to Retreatment
Infliximab for the Treatment of Moderate-to-Severe Psoriasis: Response to Retreatment. 15th Congress of the European Academy of Dermatology and Venereology, Rhodes, Greece. 2006.